Accelerate timelines and reduce risk in drug development through optimised biomarker analysis
Hear from and meet with the leading figures in biomarker analysis to explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cytometry tools impacting biomarker research & validation
Learn about the latest multiplexed tools impacting biomarker research and validation, from multi-omic cytometry through to mass spectrometry & immunoassays
Day One
Day Two
Digital Day
The 2022 event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below were some of our confirmed speakers for 2021’s Advancing Biomarker Analysis Europe: Online
Regeneron
University of Pennsylvania
Sanofi
GlaxoSmithKline
FNIH
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual experiences.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
*Free passes are only available to industry R&D or academia.